Quantcast

Latest oral mucositis Stories

2011-03-23 14:55:00

In the news release, NephRx Corp. Awarded New U.S. Patent for Oral Mucositis Agent NX002, issued 23-Mar-2011 by NephRx Corporation over PR Newswire, we are advised by the company that the original version should be disregarded. The complete, corrected release follows: NephRx Corp. Awarded U.S.

2011-03-23 06:30:00

KALAMAZOO, Mich., March 23, 2011 /PRNewswire/ -- NephRx Corporation today announced issuance of a new U.S. patent for its novel peptide NX002, which currently is in preclinical development for the treatment of oral mucositis.

2010-10-15 07:00:00

DALLAS and NEW YORK, Oct. 15 /PRNewswire/ -- Access Pharmaceuticals, Inc.

2010-10-11 07:00:00

DALLAS and NEW YORK, Oct. 11 /PRNewswire-FirstCall/ -- Access Pharmaceuticals, Inc.

2010-10-07 06:30:00

KALAMAZOO, Mich., Oct. 7 /PRNewswire/ -- NephRx Corporation today announced that a new study has shown that its novel peptide NX002 demonstrated significant efficacy when tested in an animal model of oral mucositis.

2010-09-15 07:30:00

DALLAS and NEW YORK, Sept. 15 /PRNewswire-FirstCall/ -- ACCESS PHARMACEUTICALS, INC. (OTC Bulletin Board: ACCP), a biopharmaceutical company specializing in products for cancer and supportive care, announced today it has launched www.MuGard.com.

2010-09-14 07:30:00

DALLAS, and NEW YORK, Sept. 14 /PRNewswire/ -- ACCESS PHARMACEUTICALS, INC.

2010-07-20 07:30:00

DALLAS and NEW YORK, July 20 /PRNewswire-FirstCall/ -- ACCESS PHARMACEUTICALS, INC.

2010-06-24 07:30:00

DALLAS and NEW YORK, June 24 /PRNewswire-FirstCall/ -- ACCESS PHARMACEUTICALS, INC.

2010-06-22 07:30:00

DALLAS and NEW YORK, June 22 /PRNewswire-FirstCall/ -- ACCESS PHARMACEUTICALS, INC.


Word of the Day
shotta
  • An armed gangster.
The word 'shotta' is an alteration of 'shooter'.